ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

J App Pharm Sci. 2021; 11(2): 102-105


Isolation, Characterization and Cytotoxic Potential of Desmodium oojeinensis (Roxb) H. ohashi: A threatened medicinal plant

Sparsha Bandekar, Arun B. Joshi, Anant V. Bhandarkar, Shailendra Gurav, Mythili Krishna Jeedigunta.




Abstract
Cited by 3 Articles

Desmodium oojeinensis, which belongs to the family Fabaceae, is an endangered plant native to the Himalayan and sub-Himalayan tract. The current work aimed to carry out physicochemical, phytochemical screening, isolation, and in vitro cytotoxic activity using MCF-7 and A-549 cell lines by using the sulforhodamine B method. The physicochemical parameters tested were found to comply with pharmacopoeial limits. The extract’s phytochemical screening revealed triterpenoids, alkaloids, anthraquinone glycosides, flavonoids, and carbohydrates. Four phytoconstituents belonging to the class of triterpenoids, viz. betulin, betulinic acid, 16-hydroxybetulin, and lupeol, were isolated from the ethanolic extract by column chromatography. The ethanolic extract showed moderate cytotoxic activity on the human lung cancer cell line A-549 at a concentration of 80 μg/ml and growth inhibition of 81.5%. The extract failed to hinder the growth of the human breast cancer cell line MCF-7.

Key words: Desmodium oojeinensis, Fabaceae, Betulin, Betulinic acid, 16-hydroxybetulin, lupeol.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.